University(s) dilemma: 1) old products 100 mcg/30 mcg retired, 2) new bivalents half dose cannot be initial series, 3)...
Sep 3rd 2022 8:56am EDT
University(s) dilemma: 1) old products 100 mcg/30 mcg retired, 2) new bivalents half dose cannot be initial series, 3) AE/SAE on first round, bivalent contraindicated, 4) no bivalent human data, destined to fail at half dose, 5) no short or longer-term safety data, 6) No demand https://twitter.com/p_mcculloughmd/status/1566023401956859905?s=21&t=zDrXCxQhfX6ut9vRQ8Isnw @PeterMcCulloughMDwww.PeterMcCulloughMD.com Powered by WPeMatico
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.